ArticleImmunology2014

Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.

Han Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.